RUBICON

Rubicon Research Limited, incorporated in 1999, is a pharmaceutical company specializing in the development, manufacturing, and commercialization of differentiated, high-value, complex generic and specialty formulations. Originally engaged in contract research, the company transitioned into a specialty products firm. Its operations encompass the entire drug lifecycle, including research and development, commercial manufacturing, and front-end marketing. Rubicon primarily serves the regulated U.S. market, focusing on delivering complex pharmaceutical formulations. No information is available on the company's founders, key management, subsidiaries, or stock listings.